+91 780-304-0404

Cancer Tumor Profiling Market

Global Cancer/Tumor Profiling Market Size, Share & Trends Analysis Report by Technology (Immunoassays, In Situ Hybridization, Sequencing Techniques, Mass Spectrometry, and Others), by Cancer Type (Lung Cancer, Breast Cancer, Prostate Cancer, Melanoma Cancer, and Others), and by End-User (Clinics and Hospitals, and Research Centers) and Forecast 2019-2025

Published: Nov 2019 | Report Code: | Category : Biotechnology | Delivery Format: /

Global cancer/tumor profiling market is anticipated to grow at a CAGR of 8%, during the forecast period. Cancer/tumor profiling offers much-needed information about the genes that cause cancer, which in turn, provides insights regarding the mechanism of cancer.The rising number of research projects on oncology due to the increasing prevalence of oncological disorders across the globe is one of the major factors driving the growth of the market.According to the World Health Organization (WHO), cancer is the second leading cause of mortality across the globe. In 2018, more than 9.6 million fatalities occurred across the globe due to cancer. The rising number of cases demanding for profiling kit is anticipated to drive the growth of the global cancer/tumor profiling market. The increasing use of biomarkers in tumor profiling is another factor promoting the growth of the global market. Furthermore, increasing investment in cancer research along with advancements in profiling technologies is projected to drive the growth of the global market.

Segmental Outlook  

The cancer/tumor profiling market is segmented on the basis of technology, cancer type, and end-user. Based on cancer type, breast cancer held a substantial market share in 2018, owing to the high prevalence of breast cancer. Based on end-user, the research segment is anticipated to hold significant market share due to the growing focus on biomarker discovery for drug development in addition to the rising field of personalized medicine is anticipated to fuel the growth of the research segment. Moreover, growing investment for cancer research is promoting the growth of the research segment in the cancer/tumor profiling market.

Immunoassays will be the largest segment by Technology

By technology, global cancer/tumor profiling market is divided into immunoassays, in situ hybridization, sequencing techniques, mass spectrometry, and others. Immunoassays are anticipated to hold significant share in the market, owing to their high utilization as a gold standard for conduction of large- scale tumor profiling. The profiling of tumor enables to measure the presence and concentration of analytes in a sample. The immunoassays are often used for performing cancer diagnosis, prognosis, and treat diseases.

Global Cancer/Tumor Profiling Market Share by Technology, 2018 (%)

Global Cancer/Tumor Profiling Market Share by Technology

Regional Outlook 

Global cancer/tumor profiling market is segmented on the basis ofgeography, including North America, Europe, Asia-Pacific, and Rest of the World. In 2018, North America contributes a significant share in the global cancer/tumor profiling market, owing to rapid technological advancement in cancer/tumor profiling kit. Moreover, the presence of major market players such as Illumina, Inc., QAIGEN N.V., is contributing to the growth of the market in the region. Furthermore, the rapid adoption of advanced technologies by the companies that manufactures these kits is again making a significant contribution to the growth of the market in North America. 

Global Cancer/Tumor Profiling Market Growth, by Region 2019-2025

Global Cancer/Tumor Profiling Market Share by Region

Asia-Pacific will augment with the considerable growthrate in global market

Asia-Pacific is anticipated togrow at a significant CAGR during the forecast period. This is owing to increasing government initiatives for cancer treatment and growing healthcare expenditure in emerging economies, such as India and China. According to the Indian Council of Medical Research (ICMR), in 2016, more than 1.4 million cancer cases were registered in India, which is further expected to reach 1.7 million by 2020. Due to this increase in the number of cancer cases the requirement of tumor profiling kits will increase, thereby, propelling the growth of the cancer/tumor profiling market in the region. Furthermore, increasing proteomics and genomics research, increasing investments by pharmaceutical andbiotechnology companies in cancer/tumor profiling is again fueling the growth of cancer/tumor profiling market in Asia-Pacific. 

Market Players Outlook

The key players operating in the global cancer/tumor profiling market include QIAGEN N.V., Genomic Health, Inc., Sysmex Corp., Illumina Inc., and Thermo Fisher Scientific Inc. The companies are focused on developing advanced technologies in cancer/tumor profiling market to stay competitive in the global market. Geographical expansion, merger andacquisition, partnerships andcollaborations, finding a new market or innovate in their core competency to expand individual market share are some of the key strategies adopted by major market players. For instance, in February 2019, Lunaphore Technologies S.A. launched a LabSat TM, which is advanced next-generation equipment for tissue diagnostics and cancer research.

The Report Covers

  • Market value data analysis of 2018 and forecast to 2025.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global cancer/tumor profiling market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Geography

1.2.3. By Stakeholders

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules &Regulations

3. Competitive Landscape

3.1. Company Share Analysis

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. F. Hoffmann-La Roche Ltd.

3.3.1.1. Overview

3.3.1.2. Financial Analysis

3.3.1.3. SWOT Analysis

3.3.1.4. Recent Developments

3.3.2. Genomic Health, Inc.

3.3.2.1. Overview

3.3.2.2. Financial Analysis

3.3.2.3. SWOT Analysis

3.3.2.4. Recent Developments

3.3.3. Sysmex Corp.

3.3.3.1. Overview

3.3.3.2. Financial Analysis

3.3.3.3. SWOT Analysis

3.3.3.4. Recent Developments

3.3.4. QIAGEN N.V.

3.3.4.1. Overview

3.3.4.2. Financial Analysis

3.3.4.3. SWOT Analysis

3.3.4.4. Recent Developments

3.3.5. Illumina, Inc.

3.3.5.1. Overview

3.3.5.2. Financial Analysis

3.3.5.3. SWOT Analysis

3.3.5.4. Recent Developments

4. Market Determinants 

4.1. Motivators

4.2. Restraints

4.3. Opportunities

5. Market Segmentation

5.1. Global Cancer/Tumor Profiling Market by Technology 

5.1.1. Immunoassay

5.1.2. In Situ Hybridization

5.1.3. Sequencing techniques

5.1.4. Mass spectrometry

5.1.5. Others (Microarray)

5.2. Global Cancer/Tumor Profiling Market by Cancer Type

5.2.1. Lung cancer

5.2.2. Breast cancer

5.2.3. Prostate cancer

5.2.4. Melanoma cancer 

5.2.5. Others (colorectal cancer)

5.3. Global Cancer/Tumor Profiling Market by End-User

5.3.1. Clinics and Hospitals

5.3.2. Research Centers

6. Regional Analysis

6.1. North America

6.1.1. United States

6.1.2. Canada

6.2. Europe

6.2.1. UK

6.2.2. Germany

6.2.3. Italy

6.2.4. Spain

6.2.5. France

6.2.6. Rest of Europe

6.3. Asia-Pacific

6.3.1. China

6.3.2. India

6.3.3. Japan

6.3.4. Rest of Asia-Pacific

6.4. Rest of the World

7. Company Profiles

7.1. Agilent Technologies, Inc.

7.2. Almac Group Ltd.

7.3. Biodesix, Inc.

7.4. Biospherex LLC

7.5. Cepheid

7.6. Cernostics, Inc.

7.7. F. Hoffmann-La Roche Ltd.

7.8. General Electric Co.

7.9. Genomic Health, Inc.

7.10. Illumina, Inc.

7.11. Lunaphore Technologies S.A.

7.12. Metabiomics Corp.

7.13. Myriad Genetics, Inc.

7.14. Novartis International AG

7.15. OPKO Health, Inc.

7.16. PerkinElmer Inc.

7.17. Personalis, Inc.

7.18. QIAGEN N.V.

7.19. Sysmex Corp.

7.20. Thermo Fisher Scientific Inc.

  1. GLOBAL CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  2. GLOBAL IMMUNOASSAYS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  3. GLOBAL IN SITU HYBRIDIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  4. GLOBAL SEQUENCING TECHNIQUES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  5. GLOBAL MASS SPECTROMETRY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  6. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  7. GLOBAL CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2018-2025 ($ MILLION)
  8. GLOBAL LUNG CANCER  MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  9. GLOBAL BREAST CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  10. GLOBAL PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  11. GLOBAL MELANOMA CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  12. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  13. GLOBAL CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  14. GLOBAL CLINICS AND HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  15. GLOBAL RESEARCH CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  16. GLOBAL CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY,2018-2025 ($ MILLION)
  17. NORTH AMERICAN CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  18. NORTH AMERICAN CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  19. NORTH AMERICAN CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2018-2025 ($ MILLION)
  20. NORTH AMERICAN CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  21. EUROPEAN CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  22. EUROPEAN CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  23. EUROPEAN CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2018-2025 ($ MILLION)
  24. EUROPEAN CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  25. ASIA-PACIFIC CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  26. ASIA-PACIFIC CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY , 2018-2025 ($ MILLION)
  27. ASIA-PACIFIC CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2018-2025 ($ MILLION)
  28. ASIA-PACIFIC CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  29. REST OF THE WORLD CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  30. REST OF THE WORLD CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2018-2025 ($ MILLION)
  31. REST OF THE WORLD CANCER/TUMOR PROFILING MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  1. GLOBAL CANCER/TUMOR PROFILING MARKET SHARE BY TECHNOLOGY, 2018 VS 2025 (%)
  2. GLOBAL CANCER/TUMOR PROFILING MARKET SHARE BY CANCER TYPE, 2018 VS 2025 (%)
  3. GLOBAL CANCER/TUMOR PROFILING MARKET SHARE BYEND-USER, 2018 VS 2025 (%)
  4. GLOBAL CANCER/TUMOR PROFILING MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  5. US CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
  6. CANADA CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
  7. UK CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
  8. FRANCE CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
  9. GERMANY CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
  10. ITALY CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
  11. SPAIN CANCER/TUMOR PROFILINGPRODUCTS MARKET SIZE, 2018-2025 ($ MILLION)
  12. ROE CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
  13. INDIA CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
  14. CHINA CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
  15. JAPAN CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
  16. REST OF ASIA-PACIFIC CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
  17. REST OF THE WORLD CANCER/TUMOR PROFILING MARKET SIZE, 2018-2025 ($ MILLION)
Choose License Type
    On Discount

100%
Secured Payment

Why buy from us?
  • Covers more than 15 major industries, which are further segmented into 90+ sectors
  • 65% of our clients are loyal customers
  • 120+ countries are covered in analysis
  • currently servicing 1000+ customers globally
  • 100+ paid data sources mined to research
  • Our expert team will assist you with all research need and customization
  • Our expert research analyst will resolve your every query before and after purchasing the report
Related Reports